December 12, 2025

Amgen wins FDA approval for Uplizna in generalized myasthenia gravis – The Pharma Letter

December 12, 2025

Amgen wins FDA nod for Uplizna in myasthenia gravis (AMGN) – Seeking Alpha

December 12, 2025

Here’s How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis – The Globe and Mail

December 12, 2025

FDA Approves Inebilizumab for Generalized Myasthenia Gravis – The American Journal of Managed Care® (AJMC®)

December 12, 2025

Dissecting Autoantibody Mechanisms in Myasthenia Gravis – Bioengineer.org